{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:44:52Z","timestamp":1788309892263,"version":"build-2803163510"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to examine glycolysis\/gluconeogenesis-related genes in hepatocellular carcinoma (HCC) and evaluate their potential roles in HCC progression and immunotherapy response.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data analyzed in this study were collected from GSE14520, GSE76427, GSE174570, The Cancer Genome Atlas (TCGA), PXD006512, and GSE149614 datasets, metabolic pathways were collected from MSigDB database. Differentially expressed genes (DEGs) were identified between HCC and controls. Differentially expressed glycolysis\/gluconeogenesis-related genes (candidate genes) were obtained and consensus clustering was performed based on the expression of candidate genes. Bioinformatics analysis was used to evaluate candidate genes and screen prognostic genes. Finally, the key results were tested in HCC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirteen differentially expressed glycolysis\/gluconeogenesis-related genes were validated in additional datasets. Consensus clustering analysis identified two distinct patient clusters (C1 and C2) with different prognoses and immune microenvironments. Immune score and tumor purity were significantly higher in C1 than in C2, and CD4+ memory activated T cell, Tfh, Tregs, and macrophage M0 were higher infiltrated in HCC and C1 group. The study also identified five intersecting DEGs from candidate genes in TCGA, GSE14520, and GSE141198 as prognostic genes, which had a protective role in HCC patient prognosis. Compared with the control group, the prognostic genes all showed decreased expression in HCC patients in RT-qPCR and Western blot analyses. Flow cytometry verified the abnormal infiltration level of immune cells in HCC patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Results showed that glycolysis\/gluconeogenesis-related genes were associated with patient prognosis, immune microenvironment, and response to immunotherapy in HCC. It suggests that the model based on five prognostic genes may valuable for predicting the prognosis and immunotherapy response of HCC patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1232390","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:22:23Z","timestamp":1696918943000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of subclusters and prognostic genes based on glycolysis\/gluconeogenesis in hepatocellular carcinoma"],"prefix":"10.3389","volume":"14","author":[{"given":"Dan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayinuer","family":"Aierken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/bioengineering9080396","article-title":"Bioinformatic analysis and in vitro and in vivo experiments reveal that fibrillarin participates in the promotion of lung metastasis in hepatocellular carcinoma","volume":"9","author":"Luo","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.3390\/ijms24032805","article-title":"The roles of epigenetic regulation and the tumor microenvironment in the mechanism of resistance to systemic therapy in hepatocellular carcinoma","volume":"24","author":"Oura","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.3390\/cancers14215468","article-title":"Wnt\/beta-catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma","volume":"14","author":"Leung","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S258196","article-title":"Glucometabolic reprogramming in the hepatocellular carcinoma microenvironment: cause and effect","volume":"12","author":"Tian","year":"2020","journal-title":"Cancer Manag Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754961","article-title":"Serum LAG-3 predicts outcome and treatment response in hepatocellular carcinoma patients with transarterial chemoembolization","volume":"12","author":"Guo","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.66536","article-title":"Identification and validation of a prognostic model based on three MVI-related genes in hepatocellular carcinoma","volume":"18","author":"Tang","year":"2022","journal-title":"Int J Biol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.humpath.2020.12.009","article-title":"Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes","volume":"112","author":"Torbenson","year":"2021","journal-title":"Hum Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0281","article-title":"GALAD score for hepatocellular carcinoma detection in comparison with liver ultrasound and proposal of GALADUS score","volume":"28","author":"Yang","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/cells9061370","article-title":"Biomarkers in hepatocellular carcinoma: diagnosis, prognosis and treatment response assessment","volume":"9","author":"Pinero","year":"2020","journal-title":"Cells"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.955673","article-title":"Development and verification of the glycolysis-associated and immune-related prognosis signature for hepatocellular carcinoma","volume":"13","author":"Hu","year":"2022","journal-title":"Front Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e14891","DOI":"10.7717\/peerj.14891","article-title":"High-throughput sequencing approach for the identification of lncRNA biomarkers in hepatocellular carcinoma and revealing the effect of ZFAS1\/miR-150-5p on hepatocellular carcinoma progression","volume":"11","author":"Zhu","year":"2023","journal-title":"PeerJ"},{"key":"B19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/biomedicines9020159","article-title":"Proteomic profiling and artificial intelligence for hepatocellular carcinoma translational medicine","volume":"9","author":"Moldogazieva","year":"2021","journal-title":"Biomedicines"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-2607","article-title":"A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients","volume":"70","author":"Roessler","year":"2010","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/1878-0261.12153","article-title":"Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma","volume":"12","author":"Grinchuk","year":"2018","journal-title":"Mol Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2517","article-title":"Cabozantinib enhances anti-PD1 activity and elicits a neutrophil-based immune response in hepatocellular carcinoma","volume":"28","author":"Esteban-Fabro","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1159\/000515305","article-title":"Exploring markers of exhausted CD8 T cells to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma","volume":"10","author":"Hsu","year":"2021","journal-title":"Liver Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1038\/s41467-022-32283-3","article-title":"A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinf"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling tumor infiltrating immune cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2000224","DOI":"10.1002\/advs.202000224","article-title":"Trajectory and functional analysis of PD-1(high) CD4(+)CD8(+) T cells in hepatocellular carcinoma by single-cell cytometry and transcriptome sequencing","volume":"7","author":"Zheng","year":"2020","journal-title":"Adv Sci (Weinh)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-022-02302-8","article-title":"PPP1R26 drives hepatocellular carcinoma progression by controlling glycolysis and epithelial-mesenchymal transition","volume":"41","author":"Yang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.983599","article-title":"NFYA promotes the anti-tumor effects of gluconeogenesis in hepatocellular carcinoma through the regulation of PCK1 expression","volume":"10","author":"Tsujimoto","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e686","DOI":"10.1002\/ctm2.686","article-title":"Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A","volume":"12","author":"Lei","year":"2022","journal-title":"Clin Transl Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-020-01803-8","article-title":"Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3\/miRNA-30b-5p\/MINPP1 axis","volume":"40","author":"Chen","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC","volume":"13","author":"Couri","year":"2019","journal-title":"Hepatol Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1186\/s12885-021-08442-y","article-title":"Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1577","article-title":"Hepatocellular carcinoma-circulating tumor cells expressing PD-L1 are prognostic and potentially associated with response to checkpoint inhibitors","volume":"4","author":"Winograd","year":"2020","journal-title":"Hepatol Commun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B45","doi-asserted-by":"publisher","first-page":"9862876","DOI":"10.34133\/2021\/9862876","article-title":"Responsive dual-targeting exosome as a drug carrier for combination cancer immunotherapy","volume":"2021","author":"Fan","year":"2021","journal-title":"Res (Wash D C)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"4803624","DOI":"10.34133\/2019\/4803624","article-title":"Tandem molecular self-assembly selectively inhibits lung cancer cells by inducing endoplasmic reticulum stress","volume":"2019","author":"Zheng","year":"2019","journal-title":"Res (Wash D C)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e143377","DOI":"10.1172\/JCI143377","article-title":"Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma","volume":"131","author":"Loong","year":"2021","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.895608","article-title":"Effects of glycolysis-related genes on prognosis and the tumor microenvironment of hepatocellular carcinoma","volume":"13","author":"Zheng","year":"2022","journal-title":"Front Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gastro\/goaa066","article-title":"Metabolic alterations and vulnerabilities in hepatocellular carcinoma","volume":"9","author":"Tenen","year":"2021","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.3390\/ijms24087463","article-title":"Metabolic reprogramming of HCC: A new microenvironment for immune responses","volume":"24","author":"Foglia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-11502-7","article-title":"Glycolysis-related gene signature can predict survival and immune status of hepatocellular carcinoma","volume":"29","author":"Xu","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"0036","DOI":"10.34133\/research.0036","article-title":"Comprehensive metabolic profiling and genome-wide analysis reveal therapeutic modalities for hepatocellular carcinoma","volume":"6","author":"Qi","year":"2023","journal-title":"Res (Wash D C)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"15330338211045820","DOI":"10.1177\/15330338211045820","article-title":"PD-L1(+)NEUT, foxp3(+)Treg, and NLR as new prognostic marker with low survival benefits value in hepatocellular carcinoma","volume":"20","author":"Zhou","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib","volume":"150","author":"Zhou","year":"2016","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28770","article-title":"Neutrophils recruit regulatory T-cells into tumors via secretion of CCL17\u2013a new mechanism of impaired antitumor immunity","volume":"135","author":"Mishalian","year":"2014","journal-title":"Int J Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S326535","article-title":"Comprehensive analyses of the infiltrating immune cell landscape and its clinical significance in hepatocellular carcinoma","volume":"14","author":"Zhang","year":"2021","journal-title":"Int J Gen Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13073-022-01055-5","article-title":"Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival","volume":"14","author":"Alvarez","year":"2022","journal-title":"Genome Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01000","article-title":"mTOR\/HDAC1 crosstalk mediated suppression of ADH1A and ALDH2 links alcohol metabolism to hepatocellular carcinoma onset and progression in silico","volume":"9","author":"Zahid","year":"2019","journal-title":"Front Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1186\/s12885-020-07689-1","article-title":"Prognostic implications of alcohol dehydrogenases in hepatocellular carcinoma","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Cancer"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000803","article-title":"Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob\/Akt\/PP2A protein complex","volume":"18","author":"He","year":"2020","journal-title":"PloS Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"43864","DOI":"10.1038\/srep43864","article-title":"Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression","volume":"7","author":"Yang","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1232390\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:22:26Z","timestamp":1696918946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1232390\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":61,"alternative-id":["10.3389\/fimmu.2023.1232390"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1232390","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"article-number":"1232390"}}